Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Burcon Nutrascience ( (TSE:BU) ) has issued an announcement.
Burcon NutraScience reported fiscal 2026 third-quarter revenue of $739,000, an increase of about 1,100% from a year earlier, as commercial production ramped up and recurring customer orders grew. Management said demand for its plant-based protein ingredients is outpacing expectations, with more than 200 active customer projects and clients moving from trials to larger repeat purchases.
To support this growth, Burcon is investing in expanded production capacity and operational capabilities, underpinned by a $6.9 million private placement of convertible debentures led by its manufacturing partner. Despite the revenue surge, the company posted a nine-month net loss of $10.7 million and negative working capital of $9.7 million, reflecting higher startup and production costs at its Galesburg facility even as it reduces research, development, and administrative spending to focus on commercialization.
The most recent analyst rating on (TSE:BU) stock is a Hold with a C$2.00 price target. To see the full list of analyst forecasts on Burcon Nutrascience stock, see the TSE:BU Stock Forecast page.
Spark’s Take on TSE:BU Stock
According to Spark, TipRanks’ AI Analyst, TSE:BU is a Neutral.
The score is held down primarily by very weak financial performance (deep losses, ongoing cash burn, and a highly strained capital structure with equity erosion and extreme leverage). Technical indicators provide some near-term support (positive momentum and price above short-term averages), but valuation signals remain unfavorable due to negative earnings and no dividend data.
To see Spark’s full report on TSE:BU stock, click here.
More about Burcon Nutrascience
Burcon NutraScience is a Vancouver-based technology company focused on plant-based protein innovation for the food and beverage industry. The company develops and commercializes high-purity, high-performance plant protein ingredients, working with a manufacturing partner to supply proteins for multiple consumer applications from its Galesburg production facility.
Average Trading Volume: 9,719
Technical Sentiment Signal: Sell
Current Market Cap: C$22.97M
For a thorough assessment of BU stock, go to TipRanks’ Stock Analysis page.